New combo therapy tracked in 300 colon cancer patients
NCT ID NCT07494578
First seen Mar 31, 2026 · Last updated May 17, 2026 · Updated 4 times
Summary
This study looks at how well a combination of two drugs (trifluridine/tipiracil and bevacizumab) works for people with metastatic colorectal cancer. About 300 patients across 15 Italian hospitals are being observed to see how long they live and how long the cancer stays under control. The goal is to understand the real-world benefits of this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Policlinico Universitario Agostino Gemelli
Rome, Lazio, 00160, Italy
Conditions
Explore the condition pages connected to this study.